Chemoinformaics analysis of 1-Ethyl-2-methylcyclopentene
| Molecular Weight | 110.2 | nRot | 1 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 5 |
| Exact Molecular Weight | 110.11 | nRing | 1 |
| Solubility: LogS | -2.91 | nHRing | 0 |
| Solubility: LogP | 3.163 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 22.6951 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.455 |
| Synth | 2.828 |
| Natural Product Likeliness | 0.868 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.355 |
| MDCK | 0.0000204 |
| BBB | 0.795 |
| PPB | 0.949496 |
| VDSS | 4.932 |
| FU | 0.0265805 |
| CYP1A2-inh | 0.922 |
| CYP1A2-sub | 0.675 |
| CYP2c19-inh | 0.269 |
| CYP2c19-sub | 0.482 |
| CYP2c9-inh | 0.193 |
| CYP2c9-sub | 0.748 |
| CYP2d6-inh | 0.071 |
| CYP2d6-sub | 0.401 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.207 |
| CL | 11.139 |
| T12 | 0.514 |
| hERG | 0.021 |
| Ames | 0.005 |
| ROA | 0.03 |
| SkinSen | 0.398 |
| Carcinogencity | 0.463 |
| EI | 0.969 |
| Respiratory | 0.064 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.955914 |